Ilaria Demori

Prof. Dr. Ilaria Demori

Department of Pharmacy (DIFAR), University of Genoa, Genoa, Liguria, Italy
orcid
PhD in Physiological Sciences, Research Fellow, Assistant Pr...

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Ilaria DemoriIlaria Demori
Ilaria Demori
ZRZeinab El RASHED
Zeinab El RASHED
VCViola Corradino
Viola Corradino
ACAnnamaria Catalano
Annamaria Catalano
LRLeila Rovegno
Leila Rovegno
Elena GrasselliElena Grasselli
Elena Grasselli
Amphibian skin is not to be considered a mere tegument; it has a multitude of functions related to respiration, osmoregulation, and thermoregulation, thus allowing the individuals to survive and thrive in the terrestrial environment. Moreover, amphibian skin secretions are enriched with several peptides, which defend the skin from environmental and pathogenic insults and exert many other biological effects. In this work, the beneficial effects of amphibian skin peptides are reviewed, in particular their role in speeding up wound healing and in protection from oxidative stress and UV irradiation. A better understanding of why some species seem to resist several environmental insults can help to limit the ongoing amphibian decline through the development of appropriate strategies, particularly against pathologies such as viral and fungal infections.

1 November 2006 in Alcohol
Verified
Journal Article
Closed access
Ilaria DemoriIlaria Demori
Ilaria Demori
AVAdriana Voci
Adriana Voci
EFEmilia Fugassa
Emilia Fugassa
BBBruno Burlando
Bruno Burlando

3 November 2020 in Planta Medica
Verified
Journal Article
Closed access
PDF file
ZRZeinab El Rashed
Zeinab El Rashed
EGElena Grasselli
Elena Grasselli
HKHala Khalifeh
Hala Khalifeh
LCLaura Canesi
Laura Canesi
Ilaria DemoriIlaria Demori
Ilaria Demori
Nonalcoholic fatty liver disease is a metabolic disorder characterized by lipid overloading in hepatocytes that can progress pathogenically and even end in hepatocellular carcinoma. Nonalcoholic fatty liver disease pharmacological treatment is still limited by unwanted side effects, whereas the use of food components with therapeutic potential is advisable. The culinary use of marine algae is traditional for some populations and reviving worldwide, with promising health outcomes due to the large number of bioactive compounds found in seaweeds. The present review focuses on brown-algae polysaccharides, particularly fucoidan, alginate, and laminarin, and summarizes the experimental evidence of their potential effects against nonalcoholic fatty liver disease onset and progression. In vitro and in vivo studies demonstrate that brown-algae polysaccharides exert beneficial actions on satiety feeling, caloric intake, fat absorption, and modulation of the gut microbiota, which could account for indirect effects on energy and lipid homeostasis, thus diminishing the fat overload in the liver. Specific effects against nonalcoholic fatty liver disease pathogenesis and worsening are also described and sustained by the antioxidant, anti-inflammatory, and antisteatotic properties of brown-algae polysaccharides. Further studies are required to clarify the mechanism of action of brown-algae polysaccharides on liver cells, to determine the composition and bioavailability of brown-algae polysaccharides present in different algal sources and to probe the clinical availability of these compounds in the form of algal foods, food supplements, and regulated therapeutics.

28 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
CLChiara Lambruschini
Chiara Lambruschini
Ilaria DemoriIlaria Demori
Ilaria Demori
ZRZeinab El Rashed
Zeinab El Rashed
LRLeila Rovegno
Leila Rovegno
ECElena Canessa
Elena Canessa
LMLisa Moni
Lisa Moni
The Ugi four-component reaction employing naturally occurred ferulic acid (FA) is proposed as a convenient method to synthesize feruloyl tertiary amides. Applying this strategy, a peptoid-like derivative of ferulic acid (FEF77) containing 2 additional hydroxy-substituted aryl groups, has been synthesized. The influence of the configuration of the double bond of ferulic acid and feruloyl amide on the antioxidant activity has been investigated thanks to light-mediated isomerization studies. At the cellular level, both FA, trans and cis isomers of FEF77 were able to protect human endothelial cord vein (HECV) cells from the oxidative damage induced by exposure to hydrogen peroxide, as measured by cell viability and ROS production assays. Moreover, in steatotic FaO rat hepatoma cells, an in vitro model resembling non-alcoholic fatty liver disease (NAFLD), the molecules exhibited a lipid-lowering effect, which, along with the antioxidant properties, points to consider feruloyl amides for further investigations in a therapeutic perspective.

12 January 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
Elena GrasselliElena Grasselli
Elena Grasselli
AVAdriana Voci
Adriana Voci
Ilaria DemoriIlaria Demori
Ilaria Demori
GVGiulia Vecchione
Giulia Vecchione
ACAndrea D. Compalati
Andrea D. Compalati
LVLaura Vergani
Laura Vergani
Adipose tissue, dietary lipids and de novo lipogenesis are sources of hepatic fatty acids (FFAs) that are stored in lipid droplets (LDs) as triacylglycerols (TAGs). Destiny of TAGs stored in LDs is determined by LD proteomic equipment. When adipose triglyceride lipase (ATGL) localizes at LD surface the lipid mobilization is stimulated. In this work, an in vitro model of cultured rat hepatocytes mimicking a mild steatosis condition was used to investigate the direct lipid-lowering action of iodothyronines, by focusing, in particular, on LD-associated proteins, FFA oxidation and lipid secretion. Our results demonstrate that in ‘steatotic’ hepatocytes iodothyronines reduced the lipid excess through the recruitment of ATGL on LD surface, and the modulation of the LD-associated proteins Rab18 and TIP47. As an effect of ATGL recruitment, iodothyronines stimulated the lipid mobilization from LDs then followed by the up-regulation of carnitine-palmitoyl-transferase (CPT1) expression and the stimulation of cytochrome-c oxidase (COX) activity that seems to indicate a stimulation of mitochondrial function. The lipid lowering action of iodothyronines did not depend on increased TAG secretion. On the basis of our data, ATGL could be indicated as an early mediator of the lipid-lowering action of iodothyronines able to channel hydrolyzed FFAs towards mitochondrial beta-oxidation rather than secretion.

3 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Ilaria DemoriIlaria Demori
Ilaria Demori
Elena GrasselliElena Grasselli
Elena Grasselli
The novel term metabolic dysfunction-associated fatty liver disease (MAFLD), which has been proposed to describe the major cause of hepatic disease, pinpoints the coexistence of multiple metabolic disturbances and liver steatosis, giving rise to different phenotypic manifestations. Within the psychoneuroendocrineimmunological (PNEI) network that regulates body–mind interactions, the stress response plays a pervasive role by affecting metabolic, hormonal, immune, and behavioral balance. In this perspective, we focus on chronic psychosocial stress and high levels of cortisol to highlight their role in MAFLD pathogenesis and worsening. From a PNEI perspective, considering the stress response as a therapeutic target in MAFLD allows for simultaneously influencing multiple pathways in the development of MAFLD, including dysmetabolism, inflammation, feeding behaviors, gut–liver axis, and dysbiosis, with the hope of better outcomes.